TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
7.81
-0.08 (-1.01%)
Nov 6, 2026, 1:30 PM CST
| Market Cap | 5.56B -16.5% |
| Revenue (ttm) | 256.46M +530.4% |
| Net Income | 155.12M |
| EPS | 0.21 |
| Shares Out | 711.83M |
| PE Ratio | 36.90 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,569,329 |
| Open | 7.47 |
| Previous Close | 7.89 |
| Day's Range | 7.39 - 7.95 |
| 52-Week Range | 7.47 - 16.40 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |